NAFLD and risk of cardiovascular disease

被引：3
|
作者：
Leake I.
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
Nature Reviews Gastroenterology & Hepatology | 2019年 / 16卷 / 12期
关键词：
D O I：
10.1038/s41575-019-0234-7
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：706 / 706
相关论文
共 50 条
  • [21] NAFLD in Normal Weight: hepatic and cardiovascular Risk increased
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (12):
  • [22] Cardiovascular risk factors are independent of fibrosis severity in NAFLD
    Roccarina, D.
    Buzzetti, E.
    Misas, M. G.
    Rosselli, M.
    Majumdar, A.
    Pinzani, M.
    Tsochatzis, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S154 - S154
  • [23] Cardiovascular risk factors and fibrosis severity in NAFLD: is there a link?
    Roccarina, Davide
    Prat, Laura Iogna
    Guerrero, Marta
    Buzzetti, Elena
    Mantovani, Anna
    Goyale, Atul
    Arico', Francesco
    Saffioti, Francesca
    Pinzani, Massimo
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E308 - E308
  • [24] NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)-A NEW CARDIOVASCULAR RISK FACTOR IN PERITONEAL DIALYSIS PATIENTS
    Mikolasevic, Ivana
    Milic, Sandra
    Racki, Sanjin
    Zaputovic, Luka
    Stimac, Davor
    Radic, Mladen
    Markic, Dean
    Orlic, Lidija
    PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (04): : 427 - 432
  • [25] Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
    Baratta, Francesco
    D'Erasmo, Laura
    Bini, Simone
    Pastori, Daniele
    Angelico, Francesco
    Del Ben, Maria
    Arca, Marcello
    Di Costanzo, Alessia
    ATHEROSCLEROSIS, 2022, 357 : 51 - 59
  • [26] The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
    Yang, Zifeng
    Yang, Juan
    Cai, Jingjing
    Zhang, Xiao-Jing
    Zhang, Peng
    She, Zhi-Gang
    Li, Hongliang
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (06)
  • [27] Dysregulated lipid metabolism links NAFLD to cardiovascular disease
    Deprince, Audrey
    Haas, Joel T.
    Staels, Bart
    MOLECULAR METABOLISM, 2020, 42
  • [28] CARDIOVASCULAR DISEASE AND NAFLD: DOES HISTOLOGIC SEVERITY MATTER?
    Domanski, Jeremy P.
    Park, Stephen
    Harrison, Stephen A.
    HEPATOLOGY, 2010, 52 (04) : 627A - 627A
  • [29] NAFLD and cardiovascular disease: Can the real association be determined?
    Trivedi I.
    Rinella M.E.
    Current Hepatology Reports, 2014, 13 (2) : 130 - 141
  • [30] Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
    Quentin M. Anstee
    Giovanni Targher
    Christopher P. Day
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 330 - 344
12345